search
Back to results

Reducing Blood Pressure in Mid-life Adult Binge Drinkers

Primary Purpose

Alcohol Drinking, Binge Drinking, Blood Pressure

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Training
Alcohol Abstinence Intervention
Sponsored by
The University of Texas at Arlington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alcohol Drinking focused on measuring Exercise training, High-intensity interval training, Midlife adults, Middle-aged, Microvascular function, Sympathetic nerve activity

Eligibility Criteria

50 Years - 64 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Men and women (50-64 years of age) who do not drink alcohol, who drink at moderate levels, or who binge drink
  • Female subjects will be postmenopausal (i.e., cessation of menses for ≥1 yr).
  • Subjects who can speak and understand English.

Exclusion Criteria:

  • a history of diabetes, cardiovascular disease, liver, or renal disease
  • current or history of smoking and illicit drug use
  • blood pressure ≥160/100 mm Hg
  • other known traditional cardiovascular disease risks: obesity (BMI≥35 kg/m2), or hyperlipidemia (total cholesterol>230 mg/dl and/or LDL cholesterol>160 mg/dl)
  • active infection (in the past 2 months)
  • a history of seizures, cancer, or inflammatory disease (i.e., gout or rheumatoid)
  • unstable body weight (>5% change during the past 6 months)
  • regular aerobic exercise training (i.e., they engage in 30 min of structured aerobic exercise at least 3 times per week)
  • current use of hormone replacement therapy (i.e., estrogen, progesterone, and testosterone)

Sites / Locations

  • University of Texas at ArlingtonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

Exercise Group

Non-exercise Group

Alcohol abstainer/moderate drinker group

Arm Description

Binge drinkers who have been assigned to exercise group will receive baseline assessment, 8-week exercise training plus alcohol abstinence intervention, and post-intervention assessment.

Binge drinkers who have been assigned to non-exercise group will receive baseline assessment, 8-week alcohol abstinence intervention, and post-intervention assessment.

Alcohol abstainer/moderate drinker will complete baseline assessment only and will not receive any intervention.

Outcomes

Primary Outcome Measures

Feasibility of high-intensity interval training
Recruitment capacity (e.g., how many subjects respond and enter to the study or reasons of refusal), resulting subject characteristics, the number of exercise session attended, and the number of dropouts

Secondary Outcome Measures

Changes in microvascular function
A small amount of fat will be taken form the buttock. Small vessels will then be found in the fat and their sizes in response to various flows and chemical agents will be measured.
Changes in sympathetic activity
A small electrode will be inserted into the back of the knee to record nerve activity (bursts/min).
Changes in urine catecholamine levels
Urine samples will be collected for 24 hours to measure norepinephrine levels (ug/g)
Changes in blood pressure
Systolic and Diastolic blood pressure will be measured at rest and for 24 hours.
Changes in alcohol intake
Questionnaires will be used to determine alcohol intake.

Full Information

First Posted
August 22, 2022
Last Updated
December 22, 2022
Sponsor
The University of Texas at Arlington
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05522075
Brief Title
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
Official Title
Reducing Blood Pressure in Mid-life Adult Binge Drinkers: the Role of Microvascular Function and Sympathetic Activity
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 21, 2022 (Actual)
Primary Completion Date
October 30, 2024 (Anticipated)
Study Completion Date
April 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The University of Texas at Arlington
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study has two phases: Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers. Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers
Detailed Description
During phase 1, we will measure blood pressure, microvascular function, and sympathetic nerve activity (baseline assessment) in mid-life adult binge drinkers, alcohol abstainers, and moderate drinkers. Only mid-life adult binge drinkers will enter Phase 2 and be randomized to the exercise training group and non-exercise control group. After 8 weeks of intervention, we will re-measure blood pressure, microvascular function, and sympathetic nerve activity (post-intervention assessment) in mid-life adult binge drinkers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Drinking, Binge Drinking, Blood Pressure, Alcohol Abstinence, Aging, Lifestyle Factors, Vasodilation, Behavioral Problem
Keywords
Exercise training, High-intensity interval training, Midlife adults, Middle-aged, Microvascular function, Sympathetic nerve activity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
55 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise Group
Arm Type
Experimental
Arm Description
Binge drinkers who have been assigned to exercise group will receive baseline assessment, 8-week exercise training plus alcohol abstinence intervention, and post-intervention assessment.
Arm Title
Non-exercise Group
Arm Type
Active Comparator
Arm Description
Binge drinkers who have been assigned to non-exercise group will receive baseline assessment, 8-week alcohol abstinence intervention, and post-intervention assessment.
Arm Title
Alcohol abstainer/moderate drinker group
Arm Type
No Intervention
Arm Description
Alcohol abstainer/moderate drinker will complete baseline assessment only and will not receive any intervention.
Intervention Type
Behavioral
Intervention Name(s)
Exercise Training
Intervention Description
Subjects will be asked to perform exercise training (high-intensity interval training) under supervision, 3 times per week for 8 weeks. Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.
Intervention Type
Behavioral
Intervention Name(s)
Alcohol Abstinence Intervention
Intervention Description
Subjects will be asked to abstain from alcohol for 8 weeks. Education materials and bi-weekly consultations will be provided.
Primary Outcome Measure Information:
Title
Feasibility of high-intensity interval training
Description
Recruitment capacity (e.g., how many subjects respond and enter to the study or reasons of refusal), resulting subject characteristics, the number of exercise session attended, and the number of dropouts
Time Frame
Through out the study participation (~3 months)
Secondary Outcome Measure Information:
Title
Changes in microvascular function
Description
A small amount of fat will be taken form the buttock. Small vessels will then be found in the fat and their sizes in response to various flows and chemical agents will be measured.
Time Frame
Baseline and after an 8-week intervention
Title
Changes in sympathetic activity
Description
A small electrode will be inserted into the back of the knee to record nerve activity (bursts/min).
Time Frame
Baseline and after an 8-week intervention
Title
Changes in urine catecholamine levels
Description
Urine samples will be collected for 24 hours to measure norepinephrine levels (ug/g)
Time Frame
Baseline and after an 8-week intervention
Title
Changes in blood pressure
Description
Systolic and Diastolic blood pressure will be measured at rest and for 24 hours.
Time Frame
Baseline and after an 8-week intervention
Title
Changes in alcohol intake
Description
Questionnaires will be used to determine alcohol intake.
Time Frame
Baseline and after an 8-week intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men and women (50-64 years of age) who do not drink alcohol, who drink at moderate levels, or who binge drink Female subjects will be postmenopausal (i.e., cessation of menses for ≥1 yr). Subjects who can speak and understand English. Exclusion Criteria: a history of diabetes, cardiovascular disease, liver, or renal disease current or history of smoking and illicit drug use blood pressure ≥160/100 mm Hg other known traditional cardiovascular disease risks: obesity (BMI≥35 kg/m2), or hyperlipidemia (total cholesterol>230 mg/dl and/or LDL cholesterol>160 mg/dl) active infection (in the past 2 months) a history of seizures, cancer, or inflammatory disease (i.e., gout or rheumatoid) unstable body weight (>5% change during the past 6 months) regular aerobic exercise training (i.e., they engage in 30 min of structured aerobic exercise at least 3 times per week) current use of hormone replacement therapy (i.e., estrogen, progesterone, and testosterone)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chueh-Lung Hwang, PhD
Phone
8172729722
Email
chuehlung.hwang@uta.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chueh-Lung Hwang, PhD
Organizational Affiliation
University of Texas at Arlington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas at Arlington
City
Arlington
State/Province
Texas
ZIP/Postal Code
76010
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chueh-Lung Hwang, PhD, PT
Phone
817-272-9722
Email
chuehlung.hwang@uta.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
We will submit to the NIMH Data Archive human subjects' data that were collected as part of the "Research Project" including microvascular function, sympathetic activity, and blood pressure. These data will be made accessible to authorized users for the purpose of scientific investigation, scholarship or teaching, or other forms of research and research development.
IPD Sharing Time Frame
Data will be shared with authorized users upon publication (via an NDA Study) or 1-2 years after the grant end date (04/30/2025).
IPD Sharing Access Criteria
Submit a Data Access Request to NDA and get approval
IPD Sharing URL
https://nda.nih.gov/get/access-data.html

Learn more about this trial

Reducing Blood Pressure in Mid-life Adult Binge Drinkers

We'll reach out to this number within 24 hrs